The Devyser blog

Devyser has been awarded a tender for Devyser’s CFTR fragment analysis products, that are used for...

Devyser has been awarded a tender for Devyser RHD, its product for non-invasive fetal RHD status in...

“Devyser is reporting record sales growth (+50% organic growth) for the third quarter, a further...

Dear Devyser network, partners, and valued customers,

Devyser and Thermo Fisher Scientific have entered into a collaboration agreement to promote...

Devyser and Thermo Fisher Scientific have agreed to expand commercial collaboration by including...

Devyser’s novel test for detecting donor-derived cell-free DNA in blood samples from...

Devyser has inaugurated its CLIA-certified laboratory in Atlanta, Georgia. The laboratory will...

Devyser is thrilled to announce the launch of two new products, Devyser LynchFAP and Devyser BRCA...

Fetal derived cell-free DNA (cfDNA) is a key analyte for determining fetal RHD status in plasma...

Devyser is today announcing that its product for non-invasive fetal RHD testing has been granted...

“The first quarter of the year saw continued strong growth, record gross margin and the launching...